SCHEMBL20691645

SCHEMBL20691645

CCC(C)(C)OC(=O)N1Cc2c(C(=O)OC)cnn2C[C@@H]1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 2/20 0.43
▸ DRD4 P21917 1/20 0.43
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HCRTR2 O43614 3/20 0.32
▸ GPR119 Q8TDV5 3/20 0.32
▸ TSHR P16473 1/20 0.31
▸ NR1H2 P55055 1/20 0.31
▸ NR1H3 Q13133 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ SPR P35270 2/20 0.31
▸ EED O75530 1/20 0.31
▸ RBBP4 Q09028 1/20 0.31
▸ SUZ12 Q15022 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22018067 0.90 DRD3 (0.42) DRD3DRD4GPR119TSHRNR1H2
SCHEMBL22053355 0.83 NTRK1 (0.36) GPR119
SCHEMBL22053356 0.79 DRD3 (0.48) DRD3DRD4POLBGAAGPR119
SCHEMBL20691685 0.78 MEN1 (0.39) POLBGPR119HPGDKMT2AHSD17B10
SCHEMBL22615358 0.78 MEN1 (0.39) POLBGPR119HPGDKMT2AHSD17B10
SCHEMBL17936948 0.77 SPR (0.36) DRD3DRD4GPR119TSHRKMT2A
SCHEMBL19632326 0.76 GPR119 (0.38) GPR119NR1H2KMT2ASPR
SCHEMBL21058315 0.76 GPR119 (0.38) GPR119NR1H2KMT2ASPR
SCHEMBL21260292 0.75 GPR119 (0.37) POLBGPR119SPR
SCHEMBL21058322 0.74 HDAC1 (0.38) POLBGPR119TSHRSPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019020070-A1 PIPERAZINE HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE OF SAME IN MEDICINE 江苏恒瑞医药股份有限公司 2019-01-31 — — WO disclosed
Send feedback